Sun Pharma S Q2fy24 Financial Performance Review

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Sun Pharma's Q2FY24 Financial Performance Review

ri-calendar-2-lineNov 2, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

In this financial performance review, we delve into the results of Sun Pharma for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)11,03713.1312,1452.8112,486
Total Expenses (₹crs.)8,62512.419,3413.799,695
Net Profit (₹crs.)2,26252,02217.462,375
Margin (%)20.49-1.4716.652.3719.02

 

REVENUE: 
Sun Pharma reported a total income of ₹12,486 crores in the second quarter of fiscal year 2024, representing a growth of 2.81% compared sequentially. On a year-on-year (YoY) basis, there was substantial growth, with revenue increasing by 13.13%.

 

EXPENSES: 
The company's total expenses for Q2FY24 amounted to ₹9,695 crores, indicating a modest increase of 3.79%. On a YoY basis, expenses increased by 12.41% from ₹8,625 crores in Q2FY23.

 

NET PROFIT: 
In the second quarter of fiscal year 2024, Sun Pharma reported a net profit of ₹2,375 crores, signifying an impressive increase of 17.46% compared to the net profit of ₹2,022 crores in the preceding quarter. On a YoY basis, the company demonstrated growth in profitability, with a net profit of ₹2,262 crores in Q2FY23.

 

MARGINS: Sun Pharma's margin in Q2FY24 was 19.02%, representing a positive trend with an increase from the margin of 16.65% in the preceding quarter. Year-on-year, the margin showed a slight decline of -1.47%.

 

In conclusion, Sun Pharma's financial performance in the second quarter of fiscal year 2024 reflects strong revenue growth and increased profitability, both compared to the preceding quarter and on a YoY basis. The company's margins have also improved, signifying a healthy financial performance.

 

Stay tuned for more updates on upcoming financial performances.

 


 

Related News

News Thumbnail
Quarterly Result

BLS's Q2FY24 Financial Performance Review

2 mins read. November 6, 2023 at 08:56 AM

News Thumbnail
Quarterly Result

Interglobe Aviation's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 11:31 AM

News Thumbnail
Quarterly Result

Titan's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 10:59 AM

News Thumbnail
Quarterly Result

Zomato's Q2FY24 Financial Performance Review

3 mins read. November 3, 2023 at 09:50 AM

Related Blogs

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Stock chartMutual Fund

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025

0 people read

8 mins read . Aug 18, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions